InvestorsObserver
×
News Home

Is Entasis Therapeutics Holdings Inc (ETTX) a Stock to Watch This Week?

Tuesday, December 29, 2020 10:49 AM | InvestorsObserver Analysts

Mentioned in this article

Is Entasis Therapeutics Holdings Inc (ETTX) a Stock to Watch This Week?

Overall market sentiment has been high on Entasis Therapeutics Holdings Inc (ETTX) stock lately. ETTX receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Entasis Therapeutics Holdings Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ETTX!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.

Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.

InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.

Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ETTX Stock Today?

Entasis Therapeutics Holdings Inc (ETTX) stock is lower by -9.31% while the S&P 500 has risen 0.06% as of 10:47 AM on Tuesday, Dec 29. ETTX is lower by -$0.24 from the previous closing price of $2.61 on volume of 1,124,840 shares. Over the past year the S&P 500 has risen 16.03% while ETTX is lower by -53.44%. ETTX lost -$3.36 per share in the over the last 12 months.

To see InvestorsObserver's Sentiment Score for Entasis Therapeutics Holdings Inc click here.

More About Entasis Therapeutics Holdings Inc

Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes Zoliflodacin, ETX0282CPDP, and NBP program.

Click Here to get the full Stock Score Report on Entasis Therapeutics Holdings Inc (ETTX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App